Featured Videos |view more
Video
Transcranial Magnetic Stimulation
Transcranial magnetic stimulation, or TMS, is a non-invasive form of brain stimulation, which uses magnetism to cause changes in the brain. Colleen Hanlon, PhD, discusses its use in MUSC clinical trials for the treatment of addiction.
Video
Awake Craniotomy and Tumor Resection
Abhay Varma, M.D., MUSC Health neurosurgeon at the Hollings Cancer Center, discusses the awake craniotomy and tumor resection procedure.
Video
Novel Drug Therapy in Stroke Treatment
Ali Alawieh, an M.D./Ph.D candidate at the Medical University of South Carolina (MUSC), discusses research on a novel drug therapy that could help prevent destruction of salvageable neurons after stroke.
Video
Tumor-Treating Fields for Glioblastoma and Other Brain Tumors
In this video, two MUSC Hollings Cancer Center neuro-oncologists, Scott M. Lindhorst, M.D., and David M. Cachia, M.D., discuss their experience with TTFields and the clinical trials they are leading in patients who have failed Avastin therapy.
Video
Resection of Pineocytomas Offers Symptom Relief
Sunil J. Patel, M.D., chair of the Department of Neurosurgery at MUSC, is one of a handful of surgeons in the world who resects symptomatic pineal cysts.
Video
Reanimating the Paralyzed Face
Samuel L. Oyer, M.D., discusses a technique used in facial reanimation surgery — masseter-to-facial nerve transfer — that can restore a patient’s ability to smile.
Featured Articles and Documents |view more
News
Predicting Epilepsy Surgery Outcomes with Deep Learning
Using deep learning, a subset of artificial intelligence involving statistical computation, MUSC Health neurologists have developed a new method that may one day help both patients with medication-refractory epilepsy and their physicians ...
News
Misconnections in Developmental Disorders and Addiction
Revealing possible links through genes that control brain wiring
News
Safeguarding Neurons After Stroke
Recent discoveries by a team of MUSC investigators may soon expand post-stroke treatment options.
News
A novel noninvasive therapy, tumor-treating fields (TTFields), extends survival by five months in recurrent glioblastoma disease.
Document
Safeguarding Neurons After Stroke
Researchers at MUSC are looking into a novel drug therapy that could help prevent destruction of salvageable neurons after stroke and one day expand the treatments open to patients after stroke.
MUSC Health Neurosciences ranks first in the Southeast and second in the country in National Institutes of Health neuroscience research funding. It places researchers and clinicians at each other’s side in an effort to realize the clinical promise of cutting-edge research. As a consistent leader in neuroscience advances, MUSC Health is:
